Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot ...Middle East

- News
Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot
Clinical trials have investigated pairing PARP inhibitor therapy with immunotherapy. Researchers are already looking ahead for ways to get even more benefit from PARP inhibitors plus checkpoint inhibitors in breast cancer patients. Investigators found macrophage-mediated immune suppression to be the weak spot of PARP inhibition treatment. Findings are published in Nature Cancer.

Hence then, the article about breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News